Search

Author/Creator Tiraboschi, Juan M.

1. Antiviral activity and CSF concentrations of 600/100 mg of darunavir/ritonavir once daily in HIV-1 patients with plasma viral suppression. (20th January 2015)

Authors:
Di Yacovo, Maria S.; Moltó, José; Ferrer, Elena; Curran, Adrian; Else, Laura; Gisslén, Magnus; Clotet, Bonaventura; Tiraboschi, Juan M.; Niubò, Jordi; Vila, Antonia; Zetterberg, H.; Back, David; Podzamczer, Daniel
Journal:
Journal of antimicrobial chemotherapy
Issue:
Volume 70:Number 5(2015:May)
Page Start:
1513
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Atherogenic properties of LDL particles after switching from Truvada or Kivexa plus lopinavir/r to lamivudine plus lopinavir/r: OLE-MET substudy. Issue 2 (4th March 2017)

Authors:
Saumoy, Maria; Tiraboschi, Juan M.; Ordoñez-Llanos, Jordi; Ribera, Esteban; Domingo, Pere; Mallolas, Josep; Curto, Jordi; Gatell, Josep M.; Podzamczer, Daniel
Journal:
HIV clinical trials
Issue:
Volume 18:Issue 2(2017)
Page Start:
49
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Brief Report: Pharmacokinetic/Pharmacodynamic Investigation of Single-Dose Oral Maraviroc in the Context of HIV-1 Pre-exposure Prophylaxis. (1st November 2016)

Authors:
Fox, Julie; Tiraboschi, Juan M.; Herrera, Carolina; Else, Laura; Egan, Deirdre; Dickinson, Laura; Jackson, Akil; Olejniczak, Natalia; Back, David; Khoo, Saye; Shattock, Robin; Boffito, Marta
Journal:
Journal of acquired immune deficiency syndromes
Issue:
Volume 73:Number 3(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗